Drug Shortage Report for ATORVASTATIN
| Report ID | 236985 |
| Drug Identification Number | 02348705 |
| Brand name | ATORVASTATIN |
| Common or Proper name | ATORVASTATIN |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATORVASTATIN |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-10-18 |
| Actual start date | 2024-10-16 |
| Estimated end date | 2025-06-13 |
| Actual end date | 2025-06-13 |
| Shortage status | Resolved |
| Updated date | 2025-06-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v28 | 2025-06-14 | English | Compare |
| v27 | 2025-06-13 | French | Compare |
| v26 | 2025-06-13 | English | Compare |
| v25 | 2025-05-21 | French | Compare |
| v24 | 2025-05-21 | English | Compare |
| v23 | 2025-05-14 | French | Compare |
| v22 | 2025-05-14 | English | Compare |
| v21 | 2025-05-14 | English | Compare |
| v20 | 2025-04-24 | French | Compare |
| v19 | 2025-04-24 | English | Compare |
| v18 | 2025-04-24 | English | Compare |
| v17 | 2025-03-26 | French | Compare |
| v16 | 2025-03-26 | French | Compare |
| v15 | 2025-03-26 | English | Compare |
| v14 | 2025-03-26 | English | Compare |
| v13 | 2025-03-26 | English | Compare |
| v12 | 2024-10-17 | English | Compare |
| v11 | 2024-10-16 | French | Compare |
| v10 | 2024-10-16 | English | Compare |
| v9 | 2024-10-10 | French | Compare |